Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, announces the launch of its new Brainomix 360 Next Generation platform at the International Stroke ...
Study in Lancet Digital Health represents the largest real-world evaluation of stroke AI imaging, encompassing data from more than 450,000 patients admitted to 107 NHS England hospitals over a 5-year ...
The Food and Drug Administration (FDA) has granted clearance for a new feature in Brainomix’s 360 Stroke solution, allowing physicians to evaluate ischemic core volume from universally available ...
In the United States alone, more than 795,000 people experience a stroke each year, which is about one in every 40 seconds, causing 1 in 6 deaths from cardiovascular disease. Globally, stroke is a ...
Brainomix, a company offering AI-powered imaging tools for stroke and lung fibrosis, announced the completion of an $18 million Series C investment round. The round was co-led by existing investors ...
Brainomix Ltd. raised £14 million ($18 million) in a series C financing round to expand its AI-powered imaging solution, Brainomix 360 Stroke, into the U.S. market. Funds will also go towards ...
OXFORD, England and CHICAGO, Feb. 2, 2026 /PRNewswire/ -- Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, announces the launch of its new Brainomix 360 ...
Brainomix Launches Award-Winning Next Generation Stroke AI Platform with Novel Net Water Uptake Technology at the International Stroke Conference (ISC) Brainomix 360 Stroke Next Generation has been ...
Brainomix 360 Stroke Next Generation has been awarded the prestigious Red Dot Design Award for excellence in usability and innovation An industry-first net water uptake feature unlocks deeper insights ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results